|
Disclosures
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.
It is the policy of the Johns Hopkins University School of Medicine that the faculty and provider disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity.
The participating course directors reported the following:
John Bartlett, MD
Consultant: HIV-Abbott Laboratories, GlaxoSmithKline, Inc., Pfizer Inc., Bristol-Meyers Squibb Co.,
Trish M. Perl, MD, MSc
None
Thomas C. Quinn, MD, MSc
None
The participating faculty reported the following:
Suzanne F. Bradley, MD
Consultant: GlaxoSmithKline, Inc.
Honorarium: Gilead
Jeffrey S. Duchin, MD, FACP, FIDSA
None
William P. Glezen, MD
Grants/Research Support: MedImmune
Consultant (for Influenza Only): MedImmune, Roche, GlaxoSmithKline, Inc, Sanofi Pasteur
Honorarium: MedImmune, Roche, GlaxoSmithKline, Inc., Sanofi Pasteur
Speaker Bureau: MedImmune
Thomas Inglesby, MD
None
Donald Low, MD, FRCPC
None
Kristin Nichol, MD, MPH, MBA
Grants/Research Support: GlaxoSmithKline, Inc., Sanofi Pasteur
Consultant: Novartis, GlaxoSmithKline, Inc., MedImmune
Kenneth E. Sands, MD, MPH
None
Thomas R. Talbot, MD, MPH
Grants/Research Support: Sanofi Pasteur
Honorarium: GlaxoSmithKline, Inc.
|
|